Hint mode is switched on Switch off
Cbonds API
Integrate prices, fundamentals and corporate actions into your workflow

Get Global Stock Data via API

  • Prices & history
  • Fundamentals
  • Dividends & corporate actions

Evommune, ordinary share
EVMN, US30054Y1073

FIND, SAVE & TRACK INVESTMENTS WITH CBONDS WATCHLIST

With Cbonds Watchlist you can always stay updated on your investments to make conscious decisions!

Watchlist
You need to request access
Add a stock to WL
Choose all Reset all
Save Close
Evommune, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Latest quotes

Try in 7-days Trial access

  • Get full online access to the database
  • Use our powerful bond screener
  • Track bond prices from 400+ sources
  • Smart Portfolio Monitoring
Unlock Data
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
Evommune, Inc. is a United States-based research and development company. The Company takes a tissue-based approach to advance insights and accelerate the development of transformative medicines for inflammatory diseases. It uses the skin as the lens ...
Evommune, Inc. is a United States-based research and development company. The Company takes a tissue-based approach to advance insights and accelerate the development of transformative medicines for inflammatory diseases. It uses the skin as the lens to uncover new approaches for accelerating the development of vital medicines across immunology and dermatology.
Show more Hide
  • Issuer
  • Full borrower / issuer name
    Evommune, Inc.
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NYSE
  • Ticker
    EVMN
  • Placement
    06.11.2025
  • Lock up period
    180
  • Number of papers
    9,375,000
  • Volume of raised funds
    150 mln USD
  • Raised funds in USD
    -
  • Placement share
    31.17%
  • Final placement price
    16 USD
  • Price change since placement date
    -67.94%
  • By capitalization
    481.24 mln USD

Indicators

IFRS/US GAAP reports

  • 2026

  • 2025

    • News

    All organization news

    Holders

    Industry Leaders

    Registration is required to get access.